OpenVSafe by OpenVAERS
Search V-safe

QNN-10548-13533

2 vaccinations 3 coded responses 21 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
762 / TX
Registered
2021-01-02
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-02
    Registered in v-safe
  2. 2021-01-02
    Dose 1 — Moderna
  3. 2021-01-02
    Health check-in — day 0, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  4. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-01-03
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches
    Adult check-in
  7. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-16
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-23
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-28
    Dose 2 — Moderna
  13. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Free text: Chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site
    Adult check-in
  15. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Swelling, Itching · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  16. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-18
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  21. 2021-02-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-13
    Survey response — day 42, dose 2
    MedDRA: Asthma, Pre-existing disease — Feeling: Fair
    Free text: Asthma flare up
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-07-29
    Survey response — 6 months, dose 2
    MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Gestational diabetes.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  25. 2021-07-29
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-08-02
  27. 2022-01-30
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-02Moderna
22021-01-28Moderna

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 2

2021-01-30

Systemic reaction (other): Chest pain

Release 5 — day 42, dose 2

2021-03-13

Symptoms: Asthma flare up

Release 9 — 6 months, dose 2

2021-07-29

Symptoms: Gestational diabetes.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma ✓ ✓ ✓
SDGestational diabetes ✓ · ✓
SDPre-existing disease ✓ ✓ ✓
SROChest pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release